Clinical Services: Treatment
Although there are no drugs available to restore vision lost to macular degeneration (MD), there are some available that help prevent vision from getting worse or even improve the remaining vision. One of the latest advancements in treatment of macular degeneration is Lucentis. This drug targets the VEGF (Vascular Endothelial Growth Factor) protein, which is responsible for "wet" MD by promoting growth of abnormal vessels in the retina. Lucentis blocks this VEGF, which results in the reduction of leaking and swelling in the retina.
Lucentis is administered through an injection into the eye. It is a day procedure, which is done using a topical anaesthetic to the eye. After the injection, an antibiotic drop is used in the eye for a week to help prevent infection.